Alere (ALR +7.5%) jumps after beating Q4 estimates earlier today, as losses narrowed on sharply...


Alere (ALR +7.5%) jumps after beating Q4 estimates earlier today, as losses narrowed on sharply smaller write-downs related to its health-management business.
Comments (1)
  • cholee65
    , contributor
    Comments (66) | Send Message
     
    ALR looks like a great stock to buy now. It's beaten up and they have a great business and model. ALR owes Oncovista up to $65 million in milestones from the sale of Adnagen. Oncovista ticker OVIT is trading 20 times normal volume. The ceo's last company he founded Ilex Oncology was sold to Genzyme for $1 billion. http://bit.ly/xrPxih
    29 Feb 2012, 10:44 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs